Edwards Lifesciences Corp... (EW)
NYSE: EW
· Real-Time Price · USD
75.13
-0.36 (-0.48%)
At close: May 01, 2025, 12:07 PM
-0.48% (1D)
| Bid | 75.12 |
| Market Cap | 44.01B |
| Revenue (ttm) | 5.72B |
| Net Income (ttm) | 4.17B |
| EPS (ttm) | 2.38 |
| PE Ratio (ttm) | 31.57 |
| Forward PE | 27.46 |
| Analyst | Hold |
| Ask | 75.14 |
| Volume | 974,526 |
| Avg. Volume (20D) | 5,417,661.2 |
| Open | 75.54 |
| Previous Close | 75.49 |
| Day's Range | 74.27 - 75.57 |
| 52-Week Range | 58.93 - 95.25 |
| Beta | 1.15 |
About EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the P...
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 27, 2000
Employees 15,800
Stock Exchange NYSE
Ticker Symbol EW
Website https://www.edwards.com
Analyst Forecast
According to 20 analyst ratings, the average rating for EW stock is "Hold." The 12-month stock price forecast is $79, which is an increase of 5.15% from the latest price.
Stock ForecastsEarnings Surprise
Edwards Lifesciences has released their quartely earnings
on Apr 23, 2025:
1 week ago
+6.63%
Edwards Lifesciences shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+6.92%
Edwards Lifesciences shares are trading higher after Morgan Stanley raised its price target on the stock from $70 to $75.
